Mount Auburn Hospital is pleased to announce the recent appointment of Lisa B. Weissmann, MD, as the hospital’s new Chief of Hematology/Oncology. Dr. Weissmann previously served as Mount Auburn Hospital’s Acting Chief of Hematology/Oncology since 2011.
Dr. Weissmann attended Harvard University and received her MD from New York University. She completed her postdoctoral education at Yale New Haven Hospital and an Oncology Fellowship at the Dana-Farber Cancer Institute. Dr. Weissmann joined the medical staff at Mount Auburn Hospital in 1999. Dr. Weissmann is board certified in Internal Medicine, and Oncology and currently serves as an Assistant Professor of Medicine at Harvard Medical School. Over her years in practice, Dr. Weissmann has developed a particular expertise in the treatment of breast cancer, serving on the Steering Committee of the Breast Cancer Team as well as on the Advisory Board of BreastCancer.org.
In the past 2½ years as Acting Chief of Hematology/Oncology, Weissmann has helped to develop a High Risk Genetics Clinic, implemented a computer chemotherapy ordering system, and has expanded the hospital’s Hematology/Oncology Center’s professional services. She is also a founding member of the Multidisciplinary Breast Cancer Team and oversees the weekly Tumor Board at Mount Auburn Hospital.
“Dr. Weissmann has been an asset to Mount Auburn Hospital for over a decade and will undoubtedly continue to enhance our cancer care and the services provided to our patients,” said Jeanette Clough, President and CEO of Mount Auburn Hospital. “She is passionate about patient care, teaching, and the community she serves.”
Mount Auburn Hospital’s Hematology/Oncology Center is located at 330 Mount Auburn Street in Cambridge. For more information, please visit www.mountauburnhospital.org or call (617) 497-9646.
Dr. Weissmann resides in Watertown and also serves as the Chief of Breast Oncology at The Cambridge Breast Center.